BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Fish and Richardson
Queensland Health
Daiichi Sankyo
Argus Health

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022249

« Back to Dashboard
NDA 022249 describes TREANDA, which is a drug marketed by Cephalon and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug and two Paragraph IV challenges. Additional details are available on the TREANDA profile page.

The generic ingredient in TREANDA is bendamustine hydrochloride. There are twenty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the bendamustine hydrochloride profile page.

Summary for 022249

Formulation / Manufacturing:see details

Pharmacology for NDA: 022249

Mechanism of ActionAlkylating Activity

Medical Subject Heading (MeSH) Categories for 022249

Suppliers and Packaging for NDA: 022249

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
bendamustine hydrochloride
POWDER;IV (INFUSION) 022249 NDA Cephalon, Inc. 63459-390 63459-390-08 1 VIAL, SINGLE-DOSE in 1 CARTON (63459-390-08) > 5 mL in 1 VIAL, SINGLE-DOSE
bendamustine hydrochloride
SOLUTION;IV (INFUSION) 022249 NDA Cephalon, Inc. 63459-390 63459-390-08 1 VIAL, SINGLE-DOSE in 1 CARTON (63459-390-08) > 5 mL in 1 VIAL, SINGLE-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;IV (INFUSION)Strength100MG/VIAL
Approval Date:Mar 20, 2008TE:APRLD:Yes
Patent:► SubscribePatent Expiration:Apr 26, 2031Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Sep 26, 2029Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Jul 12, 2026Product Flag?Substance Flag?Delist Request?Y

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
US Army
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus